Advancing new research

The Interlaken Leadership Awards

Interlaken Leadership Awards Recipients

Past Recipients

  • 2016 Anneke van der Kooi (Netherlands)
    Early intravenous immunoglobulin (IVIg) treatment in newly diagnosed idiopathic inflammatory myopathies (myositis): a proof of principle study.
    • Lisa Christopher-Stine (USA)
      Low Dose Intravenous and Subcutaneous IG for the Maintenance Treatment of Statin-induced Anti-HMGCR-associated Myopathy: A Prospective Pilot Study.
  • 2014 Bart Jacobs (Netherlands)
    Immunoglobulin treatment for patients with mild Guillain-Barré syndrome: an international prospective observational study.
  • 2013 Andrew J Pollard (UK)
    Intravenous immunoglobulin in the management of encephalitis in children.
    • Min-Suk Yoon (Germany)
      Effects of intrathecal application of human immunoglobulins (Igs) on rat EAN Model.
  • 2012 Josep Gamez (Spain)
    Intravenous Immunoglobulin for Preparing Myasthenia Gravis Patients for Thymectomy and Other Surgical Procedures Preventing Myasthenic Crisis.
  • 2011 Jean-Yves Delattre (France)
    IaSON: Privigen in paraneoplastic syndrome.
    • Christian Geis (Germany)
      Treatment effects of polyvalent human immunoglobulins in an animal model of Neuromyelitis optica.
    • Andreas Goebel (UK)
      Cellular and behavioural models to predict patients' responses to IgG treatment in CRPS.
    • Ruth Itzhaki (UK)
      Does Privigen affect the accumulation of Aβ and P-tau that occurs in HSV1-infected cultures of Vero cells.
    • Jens Schmidt (Germany)
      Immunoglobulin G for experimental treatment of Duchenne muscular dystrophy.